Free Alerts   Login
Health Care › Services-Business Services, Nec

OPRX Stock Price Correlated With OptimizeRx Financials

OPRX Stock Price vs. Quarterly
OPRX
Income Statement
Cash Flow
Balance Sheet

OPRX Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

OPRX Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

OPRX Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
First Light Asset Management
1,727,298 sh
-144,501 sh
-8%
$24,718
-$2,030
Blackrock.
1,134,954 sh
33,804 sh
3%
$16,241
$7,673
Vanguard Group
1,021,002 sh
28,416 sh
3%
$14,611
$6,888
Divisadero Street Capital Management
949,550 sh
949,550 sh
NEW
$13,588
$13,588
Awm Investment Company.
820,042 sh
37,471 sh
5%
$11,735
$5,647
Blair William
741,104 sh
-95,394 sh
-11%
$10,605
$4,097
Kennedy Capital Management.
490,685 sh
-64,990 sh
-12%
$7,022
$2,699
G2 Investment Partners Management
468,120 sh
66,138 sh
16%
$6,699
$955
D. E. Shaw & Co..
462,507 sh
-137,886 sh
-23%
$6,618
$1,947
Geode Capital Management
378,513 sh
35,417 sh
10%
$5,417
$2,747
Rice Hall James & Associates
342,741 sh
-44,636 sh
-12%
$4,905
$1,891
State Street
320,559 sh
-165,259 sh
-34%
$4,587
$807
Credit Suisse Ag
317,569 sh
423 sh
0%
$4,544
$2,077
Dimensional Fund Advisors
256,431 sh
-7,025 sh
-3%
$3,669
$1,619
Federated Hermes.
182,985 sh
-164,343 sh
-47%
$2,619
-$83
Northernrp
158,407 sh
5,162 sh
3%
$2,267
$1,075
Millrace Asset Group.
133,936 sh
133,936 sh
NEW
$1,917
$1,917
JPMorgan Chase
126,896 sh
1,993 sh
2%
$1,816
$844
Boothbay Fund Management
125,228 sh
71,399 sh
133%
$1,792
$1,373
Bridgeway Capital Management
124,700 sh
40,600 sh
48%
$1,784
$1,130
COMPANY PROFILE
NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS OptimizeRx is a digital health technology company
enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout
the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through an intelligent technology
platform embedded within a proprietary point-of-care network, OptimizeRx helps patients start and stay on their medications.

Free historical financial statements for OptimizeRx Corp.. See how revenue, income, cash flow, and balance sheet financials have changed over 27 quarters since 2017. Compare with OPRX stock chart to see long term trends.

Data imported from OptimizeRx Corp. SEC filings. Check original filings before making any investment decision.